4 结果
CROSS REFERENCE TO RELATED APPLICATION
This Application is a 371 of PCT/IB2012/054703 filed on Sep. 11, 2012, application which is incorporated herein by reference.
FIELD OF THE INVENTION
The present invention relates to a pharmaceutical combination and composition with antitumoral, antimetastatic
This is the United States national stage of international application PCT/US04/016647, filed 27 May 2004, which claims the benefit of the 28 May 2003 filing date of U.S. provisional application Ser. No. 60/473,806 under 35 U.S.C. .sctn.119(e).
The benefit of the May 28, 2003 filing date of
FIELD OF THE INVENTION
The present invention relates to chemical compounds that have inhibitory or enhancing effects on cytochrome P450 3A (CYP3A). The preferred inhibitors include free bases or pharmacologically acceptable salts of at least one of the following compounds: nordihydroguaiaretic acid,
TECHNICAL FIELD
This invention pertains to a method to inhibit angiogenesis by use of extracts of certain Rubus plant species and of certain other plants, and by use of gallic acid and its active derivatives.
BACKGROUND ART
Angiogenesis
In an adult, two types of blood vessels can potentially be